Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Gene vaccine protects mice against development of HER2/neu breast cancer
February 10th, 2005
Based on successful animal studies, a novel vaccine that uses immune cells as factories to produce Her2/neu protein may offer a way to treat some human breast cancers, according to researchers at The University of Texas M. D. Anderson Cancer Center. Their study, published in the online journal, Breast Cancer Research, on November 29, 2004, showed the vaccine protected 86% of experimental mice against HER2/neu-associated breast cancer, even though the tumors were implanted directly into mice. "This is an exciting strategy that seems to elicit a complete immunologic response against HER2/neu," said the study's lead author, Lawrence Lachman, PhD,...
Source: Women's Health Weekly (2005-02-10)
|
